FY2026 EPS Estimates for Revvity Raised by Zacks Research

Key Points

• Zacks Research raised Revvity’s FY2026 EPS estimate to $5.40 from $5.38, slightly above the $5.37 consensus estimate, while maintaining a “Hold” rating.
• Revvity recently surpassed quarterly expectations, reporting $1.41 EPS versus the $1.21 consensus and $729.69 million in revenue versus $702.96 million expected. However, revenue declined 1.3% year over year, and management’s FY2026 EPS guidance is $5.30–$5.40.
• The stock opened at $130.24, near its 52-week high of $133.00, while analysts maintain an overall “Hold” consensus with a $114.77 price target. Revvity also declared a quarterly dividend of $0.07 per share, representing a 0.2% annualized yield.

Revvity Inc. (NYSE:RVTY - Free Report) - Zacks Research boosted their FY2026 earnings estimates for shares of Revvity in a report issued on Friday, September 4th. Zacks Research analyst Team now expects that the company will post earnings per share of $5.40 for the year, up from their previous estimate of $5.38. Zacks Research has a "Hold" rating on the stock. The consensus estimate for Revvity's current full-year earnings is $5.37 per share. Zacks Research also issued estimates for Revvity's Q1 2027 earnings at $1.19 EPS, Q2 2027 earnings at $1.53 EPS, FY2027 earnings at $5.93 EPS, Q1 2028 earnings at $1.35 EPS and FY2028 earnings at $6.62 EPS.

Revvity (NYSE:RVTY - Get Free Report) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $1.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.21 by $0.20. The business had revenue of $729.69 million during the quarter, compared to analysts' expectations of $702.96 million. Revvity had a net margin of 8.16% and a return on equity of 8.34%. The business's revenue was down 1.3% on a year-over-year basis. During the same period last year, the firm posted $1.18 earnings per share. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS.

Several other research firms have also commented on RVTY. TD Cowen reissued a "buy" rating on shares of Revvity in a research note on Wednesday, July 15th. Wolfe Research started coverage on Revvity in a research note on Tuesday, June 2nd. They set a "peer perform" rating on the stock. Sanford C. Bernstein assumed coverage on shares of Revvity in a research note on Friday, June 26th. They issued a "market perform" rating and a $115.00 price target on the stock. Evercore reaffirmed an "outperform" rating on shares of Revvity in a research report on Wednesday, August 5th. Finally, Weiss Ratings upgraded shares of Revvity from a "sell (d+)" rating to a "hold (c-)" rating in a research note on Thursday, July 30th. Four investment analysts have rated the stock with a Buy rating and thirteen have given a Hold rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Hold" and a consensus price target of $114.77.

Revvity Trading Up 0.0%

Shares of RVTY stock opened at $130.24 on Monday. The company has a quick ratio of 1.50, a current ratio of 1.80 and a debt-to-equity ratio of 0.36. The stock has a 50-day simple moving average of $116.41 and a 200 day simple moving average of $102.29. Revvity has a fifty-two week low of $81.22 and a fifty-two week high of $133.00. The stock has a market capitalization of $14.53 billion, a P/E ratio of 62.02, a P/E/G ratio of 2.37 and a beta of 1.09.

Revvity Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Friday, October 23rd will be paid a dividend of $0.07 per share. The ex-dividend date is Friday, October 23rd. This represents a $0.28 dividend on an annualized basis and a yield of 0.2%. Revvity's payout ratio is currently 13.33%.

Institutional Investors Weigh In On Revvity

Large investors have recently modified their holdings of the stock. AQR Capital Management LLC increased its position in shares of Revvity by 5.2% during the 1st quarter. AQR Capital Management LLC now owns 8,449 shares of the company's stock worth $883,000 after purchasing an additional 420 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Revvity by 6.7% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,776 shares of the company's stock worth $1,246,000 after buying an additional 744 shares in the last quarter. Millennium Management LLC lifted its stake in shares of Revvity by 102.0% during the first quarter. Millennium Management LLC now owns 69,401 shares of the company's stock valued at $7,343,000 after acquiring an additional 35,048 shares during the period. Goldman Sachs Group Inc. boosted its stake in shares of Revvity by 45.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 607,104 shares of the company's stock valued at $64,232,000 after purchasing an additional 189,871 shares during the last quarter. Finally, Focus Partners Wealth boosted its stake in Revvity by 13.0% in the first quarter. Focus Partners Wealth now owns 7,028 shares of the company's stock valued at $744,000 after acquiring an additional 811 shares during the last quarter. 86.65% of the stock is currently owned by institutional investors.

About Revvity

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source